The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
The farnesoid X receptor (FXR) is a bile acid-regulated nuclear receptor expressed in enterohepatic tissues. In this study we investigated whether FXR is expressed by cells of innate immunity and regulates inflammation in animal models of colitis. Acute (7 days) and chronic (8 wk) colitis were induced in wild-type and FXR−/− mice by intrarectal administration of trinitrobenzensulfonic acid or by 7-day administration of 5% dextran sulfate in drinking water. The results of this experiment demonstrate that FXR is expressed by and exerts counterregulatory effects on cells of innate immunity. Exposure of LPS-activated macrophages to 6-ethyl chenodeoxycholic acid (6E-CDCA; INT-747) a synthetic FXR ligand, results in a reciprocal regulation of NF-κB dependent-genes (TNF-α, IL-1β, IL-6, COX-1, COX-2, and iNOS) and induction of SHP, a FXR-regulated gene. FXR activation stabilizes the nuclear corepressor NCoR on the NF-κB responsive element on the IL-1β promoter. Colon inflammation in Crohn’s disease patients and in rodent models of colitis is associated with a reduced expression of FXR mRNA. Using two rodent models of colon inflammation, we show that progression of these immune-mediated disorders is exacerbated in FXR−/− mice (p < 0.01). In vivo treatment with INT-747 attenuates organ injury and immune cell activation. FXR activation increased the colon expression of I-BABP, FXR, and SHP while reducing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ mRNA expression and attenuating disease severity. In aggregate, these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Vavassori et al., 2009
In the citing paper
“An additional benefit of FXR activation in the intestine is based on intestinal immunity modulation and decreased ileal bacterial invasion.[80,81]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [80]
In the citing paper
“treatment with a synthetic agonist of BAR has protective effects in mouse models of colitis, whereas BAR-deficient (Nr1h4−/−) mice exhibit exacerbated pathology (Gadaleta et al., 2011; Vavassori et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Vavassori et al., 2009
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Cited by
Items 101–200 of 657
Grau, K. R., Zhu, S., Peterson, S. T., Helm, E. W., Philip, D. T., Phillips, M. B., Hernandez, A., Turula, H., Frasse, P., Graziano, V. R., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0602-7 · Cited by 135
Gadaleta, R. M., Garcia-Irigoyen, O., Cariello, M., Scialpi, N., Peres, C., Vetrano, S., Fiorino, G., Danese, S., Ko, B., Luo, J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102719 · Cited by 125
Gut microbiome in primary sclerosing cholangitis: A review
Little, R., Wine, E., Kamath, B. M., Griffiths, A. M., & Ricciuto, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i21.2768 · Cited by 125
Liu, H., Pathak, P., Boehme, S., & Chiang, J. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069807 · Cited by 123
Bile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023745 · Cited by 119
“FXR has also been implicated in immune modulation and barrier function in the intestine [15,16].”
Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling
Dossa, A. Y., Escobar, O., Golden, J., Frey, M. R., Ford, H. R., & Gayer, C. P. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00065.2015 · Cited by 119
Gut microbiota and obesity: Role in aetiology and potential therapeutic target
Moran, C. P., & Shanahan, F. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.005 · Cited by 138
Torres, J., de Chambrun, G. P., Itzkowitz, S., Sachar, D. B., & Colombel, J.-F. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04753.x · Cited by 116
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D., & Wan, Y.-J. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 116
Development of a covalent inhibitor of gut bacterial bile salt hydrolases
Adhikari, A. A., Seegar, T. C. M., Ficarro, S. B., McCurry, M. D., Ramachandran, D., Yao, L., Chaudhari, S. N., Ndousse-Fetter, S., Banks, A. S., Marto, J. A., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0467-3 · Cited by 113
Mencarelli, A., Cipriani, S., Renga, B., Bruno, A., D'Amore, C., Distrutti, E., & Fiorucci, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045425 · Cited by 116
Self-citationBile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease
Mulak, A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210608 · Cited by 114
“pro-inflammatory cytokines such as TNF- , IFN- , interleukin-1 (IL-1 ), IL-2, and IL-6 [101].”
Positive regulation of osteogenesis by bile acid through FXR
Cho, S. W., An, J. H., Park, H., Yang, J.-Y., Choi, H. J., Kim, S. W., Park, Y. J., Kim, S. Y., Yim, M., Baek, W.-Y., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1961 · Cited by 113
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 118
Farnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 122
Jena, P. K., Sheng, L., Liu, H., Kalanetra, K. M., Mirsoian, A., Murphy, W. J., French, S. W., Krishnan, V. V., Mills, D. A., & Wan, Y. Y. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.019 · Cited by 115
Tissue-specific actions of FXR in metabolism and cancer
Gadaleta, R. M., Cariello, M., Sabbà, C., & Moschetta, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.005 · Cited by 118
Fuchs, M. (2012) · Journal of Lipids · doi:10.1155/2012/934396 · Cited by 109
Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
Hollman, D. A. A., Milona, A., van Erpecum, K. J., & van Mil, S. W. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.07.004 · Cited by 121
Kemper, J. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.11.011 · Cited by 106
Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation
Treuter, E., & Venteclef, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.008 · Cited by 119
Nuclear bile acid signaling through the farnesoid X receptor
Mazuy, C., Helleboid‐Chapman, A., Staels, B., & Lefèbvre, P. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1805-y · Cited by 122
Liu, T., Song, X., Khan, S., Li, Y., Guo, Z., Li, C., Wang, S., Dong, W., Liu, W., Wang, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32563 · Cited by 109
Interactions between bile salts, gut microbiota, and hepatic innate immunity
Schubert, K., Olde Damink, S. W. M., von Bergen, M., & Schaap, F. G. (2017) · Immunological Reviews · doi:10.1111/imr.12579 · Cited by 105
Renga, B., Mencarelli, A., Cipriani, S., D'Amore, C., Carino, A., Bruno, A., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 103
Self-citationBile acids activated receptors in inflammatory bowel disease
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103
“The activation of toll like receptor-4 (TLR-4) causes the release of NCor1 from the promoters, allowing the transcriptional activation of these genes [39].”
BackgroundSelf-citationPhysiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 112
Critical roles of bile acids in regulating intestinal mucosal immune responses
Sun, R., Xu, C., Feng, B., Gao, X., & Liu, Z. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211018098 · Cited by 118
Bile Acid Malabsorption in Inflammatory Bowel Disease
Vítek, L. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000193 · Cited by 99
Cariello, M., Piccinin, E., García‐Irigoyen, O., Sabbà, C., & Moschetta, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.019 · Cited by 111
Bile acids: From digestion to cancers
Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97
“describe a molecular mechanism whereby FXRa could inhibit immune function through NF-kB transcriptional activity repression [144].”
BackgroundMencarelli, A., Distrutti, E., Renga, B., D'Amore, C., Cipriani, S., Palladino, G., Donini, A., Ricci, P., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022978 · Cited by 97
Self-citationRepeated sleep disruption in mice leads to persistent shifts in the fecal microbiome and metabolome
Bowers, S. J., Vargas, F., González, A., He, S., Jiang, P., Dorrestein, P. C., Knight, R. D., Wright, K. P., Lowry, C. A., Fleshner, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229001 · Cited by 105
Versatile Triad Alliance: Bile Acid, Taurine and Microbiota
Duszka, K. (2022) · Cells · doi:10.3390/cells11152337 · Cited by 110
Huang, X., Zhao, W., & Huang, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.117 · Cited by 102
Thibaut, R., Gage, M. C., Pineda‐Torra, I., Chabrier, G., Venteclef, N., & Alzaid, F. (2022) · The FEBS Journal · doi:10.1111/febs.15877 · Cited by 95
Molecular features of bile salt hydrolases and relevance in human health
Chand, D., Avinash, V. S., Yadav, Y., Pundle, A. V., Suresh, C. G., & Ramasamy, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.024 · Cited by 107
Song, M., Ye, J., Zhang, F., Su, H., Yang, X., He, H., Liu, F., Zhu, X., Wang, L., Gao, P., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03173 · Cited by 108
Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression
Jahnel, J., Fickert, P., Hauer, A. C., Högenauer, C., Avian, A., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058065 · Cited by 96
Breast Milk and Solid Food Shaping Intestinal Immunity
Parigi, S. M., Eldh, M., Larssen, P., Gabrielsson, S., & Villablanca, E. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00415 · Cited by 106
Nuclear Receptor Control of Enterohepatic Circulation
Gonzalez, F. J. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120007 · Cited by 110
Winston, J. A., Rivera, A. J., Cai, J., Thanissery, R., Montgomery, S. A., Patterson, A. D., & Theriot, C. M. (2020) · Infection and Immunity · doi:10.1128/iai.00045-20 · Cited by 102
Tie, Y., Huang, Y., Chen, R., Li, L., Chen, M., & Zhang, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2265028 · Cited by 97
FXR an emerging therapeutic target for the treatment of atherosclerosis
Mencarelli, A., & Fiorucci, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00997.x · Cited by 91
Self-citationWestern Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon
Dermadi, D., Valo, S., Ollila, S., Soliymani, R., Sipari, N., Pussila, M., Sarantaus, L., Linden, J., Baumann, M., & Nyström, M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2860 · Cited by 89
Bile acids affect intestinal barrier function through FXR and TGR5
Song, G., Xie, Y., Yi, L., Cheng, W., Jia, H., Shi, W., Liu, Q., Fang, L., Xue, S., Liu, D., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1607899 · Cited by 134
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
Zollner, G., Wagner, M., & Trauner, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 96
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
(2020) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 88
The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity
He, Y., Shaoyong, W., Chen, Y., Li, M., Gan, Y., Sun, L., Liu, Y., Wang, Y., & Jin, M. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.015 · Cited by 124
Peng, X.-R., Feng, L., Jiang, W., Wu, P., Liu, Y., Jiang, J., Kuang, S., Tang, L., & Zhou, X. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.06.047 · Cited by 95
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism
Enright, E. F., Griffin, B. T., Gahan, C. G. M., & Joyce, S. A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.009 · Cited by 85
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Furukawa, M., Moriya, K., Nakayama, J., Inoue, T., Momoda, R., Kawaratani, H., Namisaki, T., Sato, S., Douhara, A., Kaji, K., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13509 · Cited by 85
Recent advances on FXR-targeting therapeutics
Panzitt, K., Zollner, G., Marschall, H., & Wagner, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111678 · Cited by 94
Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
Massafra, V., Ijssennagger, N., Plantinga, M., Milona, A., Pittol, J. M. R., Boes, M. L., & van Mil, S. W. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.001 · Cited by 85
Ho, P. P., & Steinman, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524890113 · Cited by 85
Human Postprandial Nutrient Metabolism and Low-Grade Inflammation: A Narrative Review
Meessen, E. C. E., Warmbrunn, M. V., Nieuwdorp, M., & Soeters, M. R. (2019) · Nutrients · doi:10.3390/nu11123000 · Cited by 103
Immunology of bile acids regulated receptors
Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 92
Self-citationBile acid metabolites control Th17 and Treg cell differentiation
Hang, S., Paik, D., Devlin, A. S., Jamma, T., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., Zheng, Y., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/465344 · Cited by 84
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Pandey, H., Jain, D., Tang, D. W. T., Wong, S. H., & Lal, D. (2023) · Intestinal Research · doi:10.5217/ir.2023.00080 · Cited by 100
Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders
Fiorucci, S., Giorgio, C. D., & Distrutti, E. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_227 · Cited by 86
Self-citationGut microbiome and autoimmune disorders
Shaheen, W., Quraishi, M. N., & Iqbal, T. H. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac057 · Cited by 97
The intestinal immune system and gut barrier function in obesity and ageing
Shemtov, S. J., Emani, R., Bielska, O., Covarrubias, A. J., Verdin, E. M., Andersen, J. K., & Winer, D. A. (2022) · FEBS Journal · doi:10.1111/febs.16558 · Cited by 87
Anderson, K. M., & Gayer, C. P. (2021) · Cells · doi:10.3390/cells10113206 · Cited by 91
The Immunomodulatory Role of Bile Acids
Sipka, S., & Bruckner, G. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000366100 · Cited by 80
Developments in bile salt based therapies: A critical overview
Donkers, J. M., Abbing, R. L. P. R., & van de Graaf, S. F. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.018 · Cited by 80
Lee, J., Seok, S., Yu, P., Kim, K., Smith, Z., Rivas‐Astroza, M., Zhong, S., & Kemper, J. K. (2012) · Hepatology · doi:10.1002/hep.25609 · Cited by 81
Kim, Y. S., Hurley, E., Park, Y., & Ko, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01042-9 · Cited by 94
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 90
Yang, K., Li, G., Li, Q., Wang, W., Zhao, X. X., Shao, N., Qiu, H., Liu, J., Xu, L., & Zhao, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01385-y · Cited by 107
Giordano, C., Catalano, S., Panza, S., Vizza, D., Barone, I., Bonofiglio, D., Gelsomino, L., Rizza, P., Fuqua, S. A. W., & Andò, S. (2011) · Oncogene · doi:10.1038/onc.2011.124 · Cited by 77
Shah, A., Macdonald, G. A., Morrison, M., & Holtmann, G. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000604 · Cited by 82
Rosa, V. D., Galgani, M., Santopaolo, M., Colamatteo, A., Laccetti, R., & Matarese, G. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.10.001 · Cited by 87
Renga, B., Migliorati, M., Mencarelli, A., Cipriani, S., D’Amore, C., Distrutti, E., & Fiorucci, S. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.01.008 · Cited by 79
Self-citationAttenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
Wilson, A., Almousa, A., Teft, W. A., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-58644-w · Cited by 73
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Pan, Y., Zhang, H., Li, M., He, T., Guo, S., Zhu, L., Tan, J., & Wang, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356284 · Cited by 89
Stojancevic, M., Stankov, K., & Mikov, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/538452 · Cited by 75
Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 77
Manipulation of epithelial integrity and mucosal immunity by host and microbiota‐derived metabolites
Kayama, H., & Takeda, K. (2020) · European Journal of Immunology · doi:10.1002/eji.201948478 · Cited by 81
Sun, X., Zhang, Y., Cheng, G., Zhu, T., Zhang, Z., Xiong, L., Hu, H., & Liu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115430 · Cited by 82
SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes
Balasubramaniyan, N., Luo, Y., Sun, A.-Q., & Suchy, F. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.443937 · Cited by 73
Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Samanta, S. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621999201210220442 · Cited by 81
New therapeutic avenues in ulcerative colitis: thinking out of the box
Torres, J., Danese, S., & Colombel, J. (2013) · Gut · doi:10.1136/gutjnl-2012-303959 · Cited by 74
FXR ligands protect against hepatocellular inflammation via SOCS3 induction
Xu, Z., Huang, G., Gong, W., Zhou, P., Zhao, Y., Zhang, Y., Zeng, Y., Gao, M., Pan, Z., & He, F. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.015 · Cited by 71
Immunomodulatory functions of FXR
Fiorucci, S., Zampella, A., Ricci, P., Distrutti, E., & Biagioli, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111650 · Cited by 70
Self-citationGut Microbiota‐Bile Acid Crosstalk in Diarrhea‐Irritable Bowel Syndrome
Zhan, K., Zheng, H., Jian-qing, L., Wu, H., Qin, S., Luo, L., & Huang, S. (2020) · BioMed Research International · doi:10.1155/2020/3828249 · Cited by 78
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders
Fiorucci, S., Baldoni, M., Ricci, P., Zampella, A., Distrutti, E., & Biagioli, M. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.04.008 · Cited by 73
Self-citationInhibition of Chronic Ulcerative Colitis-associated Adenocarcinoma Development in Mice by VSL#3
Talero, E., Bolivar, S., Ávila-Román, J., Alcaide, A., Fiorucci, S., & Motilva, V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000346 · Cited by 69
Self-citationThe molecular pathogenesis of cholestasis in sepsis
Bhogal, H. K., & Sanyal, A. J. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e598 · Cited by 79
Host Directed Therapy Against Infection by Boosting Innate Immunity
Bergman, P., Raqib, R., Rekha, R. S., Agerberth, B., & Gudmundsson, G. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01209 · Cited by 72
Jain, U., Lai, C.-W., Xiong, S., Goodwin, V. M., Lu, Q., Muegge, B. D., Christophi, G. P., VanDussen, K. L., Cummings, B. P., Young, E., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.019 · Cited by 67
Bile acid receptors and signaling crosstalk in the liver, gut and brain
Ferrell, J. M., & Chiang, J. Y. L. (2021) · Liver Research · doi:10.1016/j.livres.2021.07.002 · Cited by 76
FXR mediates ILC-intrinsic responses to intestinal inflammation
Fu, T., Li, Y., Oh, T. G., Cayabyab, F., He, N., Tang, Q., Coulter, S., Truitt, M., Medina, P., He, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213041119 · Cited by 75
The gut–liver axis: host microbiota interactions shape hepatocarcinogenesis
Silveira, M. A. D., Bilodeau, S., Greten, T. F., Wang, X. W., & Trinchieri, G. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.009 · Cited by 73
Role of farnesoid X receptor in inflammation and resolution
Shaik, F. B., Prasad, D. V. R., & Narala, V. R. (2014) · Inflammation Research · doi:10.1007/s00011-014-0780-y · Cited by 72
The role of bile acids in functional GI disorders
Appleby, R. N., & Walters, J. R. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12370 · Cited by 67
Tremblay, S., Romain, G., Roux, M., Chen, X.-L., Brown, K., Gibson, D. L., Ramanathan, S., & Menendez, A. (2017) · Infection and Immunity · doi:10.1128/iai.00942-16 · Cited by 65
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Gadaleta, R. M., Cariello, M., Crudele, L., & Moschetta, A. (2022) · Nutrients · doi:10.3390/nu14153212 · Cited by 65
A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor
Li, G., Lin, W., Araya, J. J., Chen, T., Timmermann, B. N., & Guo, G. L. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.11.006 · Cited by 70
Microbiome to Brain: Unravelling the Multidirectional Axes of Communication
Aidy, S. E., Stilling, R. M., Dinan, T. G., & Cryan, J. F. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-20215-0_15 · Cited by 69
Metadata
- Authors
- Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6251-6261
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125524268
- Cited by
- 655
- References
- 34
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 49 · 2023: 52 · 2022: 71 · 2021: 56 · 2020: 55 · 2019: 40 · 2018: 34 · 2017: 36 · 2016: 31 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 25
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- farnesoid X receptor, intestinal innate immunity, colitis, Crohn's disease, NF-κB, SHP, NCoR, macrophages, chenodeoxycholic acid, trinitrobenzene sulfonic acid, dextran sulfate, TNF-α, IL-1β, interleukin-6, intestinal inflammation, nuclear receptors, intestinal homeostasis
- MeSH terms
- Receptor, Farnesoid X-Activated, Acute Disease, Adult, Animals, Chronic Disease, Colitis, Crohn Disease, Female, Humans, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Trinitrobenzenesulfonic Acid, NF-kappa B, Mice, SCID, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.